Select a community
All Communities
Home > Community Treatment Reports > Align Probiotic Treatment Report
What is Align Probiotic?

Align is a daily dietary supplement that works naturally to help build and maintain a healthy, balanced digestive system. Align capsules contain Bifantis, a unique probiotic strain that has been clinically proven to build and maintain a strong, healthy digestive system.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken
# of patients Efficacy
Major
Moderate
Slight
None
Can’t tell 		# of patients evaluated by
Bowel problems 3 0
General health 3 2
Irritable Bowel Syndrome (IBS) 2 1
Constipation 2 1
Digestive problems 1 0
Other 1 0

See all 11 patients currently taking Align Probiotic

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
4 100%

Most commonly reported side effects

Migraine
1 100%
  • Mild
  • Moderate
  • Severe

Dosages

  daily 1 mg daily 1 other daily 4 mg daily 70 mg daily
  1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 6 Number of Patients: 6 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Align Probiotic (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
2 50% Did not seem to work: 50%
Expense
1 25% Expense: 25%

See all 3 patients who’ve stopped taking Align Probiotic

Duration See details about how long patients take this treatment ▼

Currently Taking Align Probiotic

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Align Probiotic

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
4 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 25%
Not at all
3 75%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
1 25%
$25-49
3 75%
< $25
0 0%

Report created on March 21, 2010.